Bio-Techne TECH Return on invested capital
Return on invested capital at other companies
Other financials
Where this comes from
Calculated from Bio-Techne’s reported figures.
Based on trailing twelve months.
The official record: Bio-Techne’s 10-Q, filed May 8, 2025, on SEC EDGAR. View the filing →
Ask your AI about Bio-Techne's return on invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Techne's return on invested capital?
- Bio-Techne (TECH) reported return on invested capital of 5.9% in Q1 2025.
- How has Bio-Techne's return on invested capital changed year-over-year?
- Bio-Techne's return on invested capital decreased by 38.6% year-over-year, from 9.7% to 5.9%.
- What is the long-term trend for Bio-Techne's return on invested capital?
- Over 2 years (2022 to 2024), Bio-Techne's return on invested capital has grown at a -24.2% compound annual growth rate (CAGR), from 14.2% to 8.2%.
- What does return on invested capital mean?
- The after-tax return the business earns on all the capital — debt and equity — invested in it.
- How do you interpret return on invested capital?
- The cleanest measure of business quality: ROIC sustained above the cost of capital creates value, below it destroys value. Compare against WACC, not against zero.
- How does return on invested capital compare across companies?
- Highly comparable across companies as a quality screen. Sector-sensitive definitions of invested capital mean banks/insurers are best excluded.